![5'DMT-LNA-N6-Bz-C; N4-Benzoyl-5’-O-(4,4’-dimethoxytrityl)-2’-O,4’-C-methylenecytidine;Benzamide, N-[1-[2,5-anhydro-4-C-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-α-L-lyxofuranosyl]-1,2-dihydro-2-oxo-4-pyrimidinyl]- |206055-73-4](https://drjcrbio.com/wp-content/uploads/206055-73-4.png)
5’DMT-LNA-N6-Bz-C; N4-Benzoyl-5’-O-(4,4’-dimethoxytrityl)-2’-O,4’-C-methylenecytidine;Benzamide, N-[1-[2,5-anhydro-4-C-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-α-L-lyxofuranosyl]-1,2-dihydro-2-oxo-4-pyrimidinyl]- |206055-73-4
Description
| Code: JYSR-NS12 |
| CAS: 206055-73-4 |
| Chemical Formula:C38H35N3O8 |
| Molecular Weight:661.71 |
| Category: Reference Standards/API Drug Metabolites/EP Impurities/USP Impurities |
| Literature: |
| Application: 5’DMT-LNA-N6-Bz-C; N4-Benzoyl-5’-O-(4,4’-dimethoxytrityl)-2’-O,4’-C-methylenecytidine;Benzamide, N-[1-[2,5-anhydro-4-C-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-α-L-lyxofuranosyl]-1,2-dihydro-2-oxo-4-pyrimidinyl]- |206055-73-4 is useful as reference Impurity standard. |
